Balance Sheet for LIMN - findataslice
 Liminatus Pharma, Inc.
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Jun-302025-Mar-31
Fiscal PeriodQ2-FY2025Q1-FY2025
Total Assets1,908,781$5,408,859$
Total Current Assets1,782,308$5,281,643$
Cash and Cash Equivalents
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets126,473$127,216$
Goodwill
Other Intangible Assets
Physical Assets198$941$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities10,716,193$1,060$24,748,922$
Total Current Liabilities10,515,743$24,748,922$
Accounts Payable
Short Term Debt
Short Term Capital Lease Obligations
Other Current Liabilities
Total Noncurrent Liabilities200,450$1,060$0$
Long Term Debt
Long Term Capital Lease Obligations
Other Noncurrent Liabilities
Total Equity(8,807,412$)(19,667,589$)(19,340,063$)(18,508,939$)(17,547,732$)
Equity to Minority
Equity to Common Shareholders(8,807,412$)(19,667,589$)(19,340,063$)(18,508,939$)(17,547,732$)
Additional Paid-In Capital20,069,442$10$9,323,403$
Retained Earnings(28,879,455$)(1,060$)(28,665,216$)
Treasury Stock
Capital Lease Obligations